RxDoctor Payments Data

Gregory McLennan, MD

Urology · Saint Louis, MONPI 1912160052

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $54,968 of the $88,967 with a category attached, or 61.8%. Calyxo, Inc. accounts for 65.1% of it on its own, with 59 other manufacturers making up the rest. 2025 is the largest year on record at $59,699, more than ten times the $2,999 reported in 2019. Among urology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$88,967in general payments, 2019–2025

Across 836 payments — averaging $106.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Calyxo, Inc.$58K
  • Boston Scientific$7K
  • AbbVie$4K
  • Procept Biorobotics Corporation$3K
  • Teleflex LLC$2K
  • Intuitive Surgical$1K
  • plus $13K from 54 others

What the payments were for

  • Consulting fees$54,96862%
  • Speaking & faculty fees$2,9753%
  • Travel & lodging$11,75813%
  • Food & beverage$19,01421%
  • Education$2440%
  • Gifts$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Calyxo, Inc.81$57,940
Boston Scientific75$7,492
AbbVie(2 entities)89$4,065
Procept Biorobotics Corporation31$3,098
Teleflex LLC22$1,771
Intuitive Surgical15$1,436
Neotract Inc.16$1,321
Medtronic(2 entities)20$1,117
Astellas Pharma US Inc59$991
Histosonics, Inc.5$848
Coloplast88$789
KARL Storz Endoscopy-america4$643
Johnson & Johnson(2 entities)25$565
Urogen Pharma, Inc.21$555
Endo Pharmaceuticals Inc.35$482
Myriad Genetic Laboratories, Inc.20$473
Sumitomo Pharma America, Inc.23$394
Merck20$367
Rochester Medical Corporation12$309
Conmed Corporation1$300
Axonics, Inc.9$265
Olympus America Inc.7$264
Baxter Healthcare3$238
Ferring Pharmaceuticals Inc.9$236
C. R. Bard, Inc. & Subsidiaries6$193
Agiliti Health, Inc.5$193
Antares Pharma, Inc.9$179
Tolmar, Inc.16$169
Laborie Medical Technologies Corp.3$145
Acerus Pharmaceuticals Corporation7$137
Cook Medical LLC2$134
Progenics Pharmaceuticals, Inc.6$122
Bayer7$116
Endo USA, Inc.5$111
Convatec Inc.6$108
SRS Medical Systems, Inc.2$107
Blue Earth Diagnostics5$104
Aytu Biopharma, Inc.5$96
Myovant Sciences Inc.5$93
Clarus Therapeutics Inc.5$92
ABC Home Medical Supply, Inc.5$87
Travere Therapeutics, Inc.4$76
Pfizer5$74
Seagen Inc.5$74
Dendreon Pharmaceuticals LLC3$72
Tolmar Pharmaceuticals, Inc.3$48
Civco Medical Instruments2$37
Novo Nordisk2$35
BD1$35
Hologic Sales And Service, LLC2$34
AstraZeneca2$33
Azurity Pharmaceuticals, Inc.2$32
Verity Pharmaceuticals Inc.1$27
Urovant Sciences Inc2$26
Photocure Inc1$23
Sanofi1$21
Sun Pharmaceutical Industries Inc.1$20
Lantheus Medical Imaging, Inc.1$18
Vertex1$17
E.r. Squibb & Sons, L.L.C.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$88,967 in reported general payments places this provider in the 95th percentile of 250 urology providers in Missouri.

See all urology providers in Missouri

Medicare billing

Part B allowed, 2024
$319,204
Medicare patients
761
Services billed
4,718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron315$218,928
GemtesaVibegron175$127,742
Mirabegron ErMirabegron21$13,671
Tamsulosin Hcl798$9,504
Testosterone24$3,150
Finasteride242$2,729
Potassium Citrate ErPotassium Citrate40$2,408
Methenamine Hippurate40$2,060
Oxybutynin Chloride ErOxybutynin Chloride99$1,887
Solifenacin Succinate18$1,265
NitrofurantoinNitrofurantoin Macrocrystal31$1,228
Testosterone Cypionate75$1,139
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen266$1,111
Celecoxib27$1,034
Bethanechol Chloride16$1,030

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$991$218,928315 claims
Sumitomo Pharma America, Inc.Gemtesa$394$127,742175 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 250 urology providers in Missouri.

Other urology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →